10.21147/j.issn.1000-9604.2021.03.01
Chinese Society of Clinical Oncology(CSCO)diagnosis and treatment guidelines for malignant lymphoma 2021(English version)
1.General guidelines
2.Diagnosis
3.Staging
4.Treatment
4.1 Diffuse large B-cell lymphoma(DLBCL)
4.2 Follicular lymphoma(FL)
4.3 Mantle cell lymphoma(MCL)
4.4 Marginal zone lymphoma(MZL)
4.5 Burkitt lymphoma(BL)
4.6 CLL/Small lymphocytic lymphoma(SLL)
4.7 Extra-nodal natural killer/T-cell lymphoma(ENKTCL),nasal type
4.8 Peripheral T-cell lymphoma(PTCL)
4.9 HL
4.10 Primary central nervous system lymphoma
5.Prognosis
Lymphomas are a group of heterogeneous diseases,which is divided into two main categories:Hodgkin lymphoma(HL)and non-Hodgkin lymphoma(NHL).There is an estimated 75,400 incidence cases and 40,500 deaths annually in China,of which NHL accounts for about 90％of lymphoma burden(1,2).
33
2021-08-25（万方平台首次上网日期，不代表论文的发表时间）
共13页
289-301
